MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

The Medicines Company Company Profile (NASDAQ:MDCO)

Consensus Ratings for The Medicines Company (NASDAQ:MDCO) (?)
Ratings Breakdown: 3 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $35.13 (4.91% upside)

Analysts' Ratings History for The Medicines Company (NASDAQ:MDCO)
Show:
DateFirmActionRatingPrice TargetActions
7/10/2015OppenheimerReiterated RatingSector PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/6/2015MizuhoUpgradeNeutral -> Buy$28.00 -> $41.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/2/2015RBC CapitalReiterated RatingBuy$39.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/24/2015Leerink SwannBoost Price TargetOutperform$33.00 -> $35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/2/2015GuggenheimSet Price TargetBuy$42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/9/2015RBC CapitalReiterated RatingOutperform$38.00 -> $39.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015JPMorgan Chase & Co.Boost Price TargetOverweight$31.00 -> $32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015Leerink SwannLower Price TargetOutperform$35.00 -> $33.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/16/2015Citigroup Inc.Set Price TargetHold$30.00 -> $32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/10/2015MizuhoLower Price TargetNeutral$30.00 -> $27.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/27/2015Citigroup Inc.Initiated CoverageNeutral$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/19/2015MizuhoInitiated CoverageNeutral$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/26/2015Citigroup Inc.Boost Price TargetNeutral$27.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/21/2015Leerink SwannUpgradeMarket Perform -> Outperform$24.00 -> $31.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/20/2014Credit SuisseUpgradeNeutral -> Outperform$27.00 -> $33.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/28/2014Credit SuisseReiterated RatingNeutral$24.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/23/2014Citigroup Inc.Reiterated RatingNeutral$30.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/23/2014Bank of AmericaLower Price TargetBuy -> Neutral$37.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/10/2014Credit SuisseReiterated RatingNeutral$28.00 -> $26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/17/2014Leerink SwannDowngradeOutperform -> Market Perform$30.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/2/2014Piper JaffrayDowngradeOverweight -> Neutral$41.00 -> $29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/13/2014RBC CapitalLower Price TargetOutperform$50.00 -> $44.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/13/2014Credit SuisseDowngradeOutperform -> Neutral$45.00 -> $35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/13/2014Jefferies GroupDowngradeBuy -> Hold$38.50 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/5/2013RBC CapitalBoost Price TargetOutperform$41.00 -> $50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/10/2013Leerink SwannReiterated RatingOutperform$40.00 -> $42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/15/2013Bank of AmericaUpgradeNeutral -> Buy$36.00 -> $40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/6/2013RBC CapitalBoost Price TargetOutperform$41.00 -> $42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/29/2013 forward)